brain health

Big picture: Dr. Adriana Davis “I have exciting and hopeful news for migraine sufferers with heart disease!”

In the news: The FDA has approved a new nasal spray, Pfizer’s Zavzpret (Zavegepant), for the treatment of migraines.

Key Point: In general, drugs used to treat acute migraine should be used with caution in people with heart disease. The good news here is that Zavzpret is a new class of drug that can be safely administered to people with heart disease.

Did you know that 14,196 people died from heart disease in Arizona in 2020?

Want to improve your health?

What doctors think about migraines and heart disease

Know this: “Most of the drugs that treat acute migraines constrict blood vessels. This constriction can lead to strokes and heart attacks in people with heart disease. What’s great here is that Zavzpret It’s a spray, and it’s something that people who experience nausea can easily take, part of their migraine symptoms.” Dr. Puja Upal, Family Medicine.

Next steps: if you do not have heart disease I found Zavzpret to be too expensive. ZomigThis is an inexpensive but effective option for those who live in Cochise County.

The NIH has a comprehensive page on migraines. (read here)

Quick stats: Percentage of adults experiencing severe headache or migraine in the past 3 months, by sex and age ￢Taya National Health Interview Survey, United States, 2018 (CDC)

did you know Migraines can be very debilitating, and if the condition makes it impossible to work, will the government ever allow me to apply for Social Security Disability Benefits?

In Cochise County, 15.2% of adults say they have a mental health problem. Migraines can affect mental health.

What they say:

“Pfizer’s treatment applies a different approach than some other products, which doctors say may be safer for people at risk of heart attack and stroke.new york times)

“Zavegepant 10 mg nasal spray was effective in the acute treatment of migraine with a good tolerability and safety profile. To establish long-term safety and consistency of effect across attacks, Additional tests are required.” (Primary information)

sauce:

neurology live Published a comprehensive summary of Pfizer’s research. Zavegepant Becomes First FDA-Approved CGRP-Targeting Nasal Spray for Acute Migraines (read here)

Migraine Statistics: (AMF)

Pfizer estimates that nearly 40 million people in the United States suffer from migraines each year.

Migraines affect nearly 10% of the population worldwide.

5.9% of adults in Cochise County have some form of heart disease.

health standards newswire